Literature DB >> 17485006

Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage.

Daichi Shimbo1, Thomas G Pickering, Tanya M Spruill, Dennis Abraham, Joseph E Schwartz, William Gerin.   

Abstract

BACKGROUND: Home blood pressure (HBP) monitoring plays an increasingly important role in the diagnosis and treatment of hypertension. We evaluated the independent value of HBP compared with ambulatory blood pressure (ABP) and office blood pressure (OBP) in the prediction of cardiovascular end-organ damage in normotensive subjects and untreated patients with mild hypertension.
METHODS: One hundred sixty-three subjects underwent measurements of OBP, HBP, ABP, and echocardiography. A physician using a mercury-column sphygmomanometer performed three OBP measurements. The ABP was recorded using a noninvasive ambulatory monitor (mean, 35.4 awake readings per subject). Participants took HBP readings with an automatic, oscillometric device over a 10-week period (mean, 277.9 readings per subject). The left-ventricular mass index (LVMI) was calculated from measurements obtained from two-dimensionally guided M-mode or linear tracings on echocardiography.
RESULTS: For systolic and diastolic blood pressures (SBP/DBP), the correlation coefficients of the LVMI with OBP, awake ABP, and HBP were 0.29/0.27, 0.41/0.26, and 0.47/0.35, respectively (all P < .01). In a multivariate regression analysis in which age, sex, body mass index, OBP, awake ABP, and HBP were included, only age, sex, and HBP were significant predictors of LVMI. When only the first 12 home readings were used, the superiority of HBP was no longer evident.
CONCLUSIONS: In contrast to OBP and ABP, HBP measurements, when averaged over a 10-week period, are independently related to LVMI. The HBP adds prognostic information over and above OBP and ABP in the prediction of cardiovascular end-organ damage, but this relationship appears to depend on the number of readings taken.

Entities:  

Mesh:

Year:  2007        PMID: 17485006      PMCID: PMC1931502          DOI: 10.1016/j.amjhyper.2006.12.011

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  28 in total

1.  Home blood pressure measurement: reproducibility and relationship with left ventricular mass.

Authors:  R H Kok; F W Beltman; W F Terpstra; A J Smit; J F May; P A de Graeff; B Meyboom-de Jong
Journal:  Blood Press Monit       Date:  1999-04       Impact factor: 1.444

Review 2.  Ambulatory blood-pressure monitoring.

Authors:  Thomas G Pickering; Daichi Shimbo; Donald Haas
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

3.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

4.  Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel.

Authors:  T Pickering
Journal:  Am J Hypertens       Date:  1996-01       Impact factor: 2.689

5.  Trunk control as an early predictor of comprehensive activities of daily living function in stroke patients.

Authors:  Ching-Lin Hsieh; Ching-Fan Sheu; I-Ping Hsueh; Chun-Hou Wang
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

Review 6.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 7.  Home blood pressure measurement: a systematic review.

Authors:  Willem J Verberk; Abraham A Kroon; Alfons G H Kessels; Peter W de Leeuw
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

8.  National standard for measurement of resting and ambulatory blood pressures with automated sphygmomanometers.

Authors:  W B White; A S Berson; C Robbins; M J Jamieson; L M Prisant; E Roccella; S G Sheps
Journal:  Hypertension       Date:  1993-04       Impact factor: 10.190

9.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

10.  The prognostic value of ambulatory blood pressures.

Authors:  D Perloff; M Sokolow; R Cowan
Journal:  JAMA       Date:  1983-05-27       Impact factor: 56.272

View more
  16 in total

Review 1.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

Review 2.  Home blood pressure monitoring is better predictor of cardiovascular disease and target organ damage than office blood pressure: a systematic review and meta-analysis.

Authors:  Sandra C Fuchs; Renato G B de Mello; Felipe C Fuchs
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

Review 3.  Home Blood Pressure Monitoring.

Authors:  Jacob George; Thomas MacDonald
Journal:  Eur Cardiol       Date:  2015-12

Review 4.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

Review 5.  KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline.

Authors:  Holly J Kramer; Raymond R Townsend; Karen Griffin; Joseph T Flynn; Daniel E Weiner; Michael V Rocco; Michael J Choi; Matthew R Weir; Tara I Chang; Rajiv Agarwal; Srinivasan Beddhu
Journal:  Am J Kidney Dis       Date:  2019-04       Impact factor: 8.860

Review 6.  Methods of Blood Pressure Measurement to Predict Hypertension-Related Cardiovascular Morbidity and Mortality.

Authors:  Thwe Htay; Damaris Rosado; Dale Quest; Jessica Giller; Najjar Haya; Sarah Ream; Jorge Cervantes
Journal:  Curr Cardiol Rep       Date:  2022-02-09       Impact factor: 2.931

7.  Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures.

Authors:  Daichi Shimbo; Sujith Kuruvilla; Donald Haas; Thomas G Pickering; Joseph E Schwartz; William Gerin
Journal:  J Hypertens       Date:  2009-09       Impact factor: 4.844

8.  Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT.

Authors:  Charles A German; Tali Elfassy; Matthew J Singleton; Carlos J Rodriguez; Walter T Ambrosius; Joseph Yeboah
Journal:  Am J Hypertens       Date:  2021-09-22       Impact factor: 2.689

9.  Ambulatory arterial stiffness indices and target organ damage in hypertension.

Authors:  Manuel Angel Gómez-Marcos; José Ignacio Recio-Rodríguez; Ma Carmen Patino-Alonso; Leticia Gómez-Sánchez; Cristina Agudo-Conde; Marta Gómez-Sánchez; Emiliano Rodríguez-Sánchez; Luís García-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2012-01-27       Impact factor: 2.298

Review 10.  Recommendations for home blood pressure monitoring in Latin American countries: A Latin American Society of Hypertension position paper.

Authors:  Raúl Villar; Ramiro A Sánchez; José Boggia; Ernesto Peñaherrera; Jesús Lopez; Weimar Sebba Barroso; Eduardo Barbosa; Leonardo Cobos; Rafael Hernández Hernández; José Andrés Octavio; José Z Parra Carrillo; Agustín J Ramírez; Gianfranco Parati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.